• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    35.37 Up 1.67(4.96%) Feb 11, 4:00PM EST
    |After Hours : 37.25 Up 1.88 (5.32%) Feb 11, 4:46PM EST
    Prev Close:33.70
    Open:32.92
    Bid:33.00 x 100
    Ask:37.00 x 1000
    1y Target Est:70.86
    Beta:-0.041096
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:31.55 - 36.56
    52wk Range:31.25 - 58.46
    Volume:2,336,310
    Avg Vol (3m):1,122,940
    Market Cap:3.05B
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 4.96%3.05B
    LLYDown 2.26%75.63B
    PFEDown 1.22%179.83B
    ABTDown 2.34%54.21B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):146.94
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-1.03
    Quarterly EPS Est (Dec-15) :-0.32
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):3.44

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback